Cellply vs Mironid
Cellply vs Mironid, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellply is on 52/100 and Mironid on 59/100.
Where each one leads
Cellply
- headcount: 25 against 16
- LinkedIn following: 9,134 against 1,388
Mironid
- our overall score: 59/100 against 52/100
- funding raised: $46.0M against $7.2M
At a glance
| Measure | Cellply | Mironid |
|---|---|---|
| What it is | DeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics. | Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD). |
| Category | Biotechnology, HealthTech, Artificial Intelligence, Medical Devices | Biotechnology, Pharmaceuticals, Drug Discovery, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Platform |
| Founded | 2013 | 2015 |
| Headquarters | Bologna, Italy | Glasgow, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Cellply | Mironid |
|---|---|---|
| Employees | 25 | 16 |
| Total funding | $7.2M | $46.0M |
| Latest round | Funding Round | Series B |
| LinkedIn followers | 9,134 | 1,388 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cellply | Mironid |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 52/100 | 59/100 |
| Traction | 48/100 | 51/100 |
| Team | 60/100 | 70/100 |
| Community | 15/100 | Not published |
| Search visibility | 33/100 | 20/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (21/100) |
| Domain ratingLink authority, 0-100 | Not published | 13/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cellply | Mironid |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery, Tailwind CSS, Bootstrap |
Cellply vs Mironid: common questions
Which is better, Cellply or Mironid?
On our 0-100 score Mironid rates higher (59/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Cellply and Mironid compare on the numbers?
Cellply leads on headcount (25 against 16), LinkedIn following (9,134 against 1,388). Mironid leads on our overall score (59/100 against 52/100), funding raised ($46.0M against $7.2M).
Read the full Cellply review and pricing or the Mironid review and pricing. You can also browse other Cellply alternatives we track.